Gerald S. Gilchrist

4.4k total citations
87 papers, 3.1k citations indexed

About

Gerald S. Gilchrist is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Gerald S. Gilchrist has authored 87 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 21 papers in Public Health, Environmental and Occupational Health and 18 papers in Surgery. Recurrent topics in Gerald S. Gilchrist's work include Acute Lymphoblastic Leukemia research (21 papers), Hemophilia Treatment and Research (12 papers) and Childhood Cancer Survivors' Quality of Life (11 papers). Gerald S. Gilchrist is often cited by papers focused on Acute Lymphoblastic Leukemia research (21 papers), Hemophilia Treatment and Research (12 papers) and Childhood Cancer Survivors' Quality of Life (11 papers). Gerald S. Gilchrist collaborates with scholars based in United States, Switzerland and Egypt. Gerald S. Gilchrist's co-authors include John H. Edmonson, Paula J. Schomberg, Brian P. Mullan, E. Omer Burgert, Douglas M. Howarth, Gregory A. Wiseman, Mary J. Waskerwitz, Richard T. O’Brien, Denman Hammond and Harland N. Sather and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Gerald S. Gilchrist

84 papers receiving 2.9k citations

Peers

Countries citing papers authored by Gerald S. Gilchrist

Since Specialization

Citations

This map shows the geographic impact of Gerald S. Gilchrist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald S. Gilchrist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald S. Gilchrist more than expected).

Fields of papers citing papers by Gerald S. Gilchrist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald S. Gilchrist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald S. Gilchrist. The network helps show where Gerald S. Gilchrist may publish in the future.

Co-authorship network of co-authors of Gerald S. Gilchrist

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald S. Gilchrist. A scholar is included among the top collaborators of Gerald S. Gilchrist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald S. Gilchrist. Gerald S. Gilchrist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Federation of Pediatric Organizations Subspecialty Forum 2001 ·The Journal of Pediatrics ·M. Douglas Jones, Thomas F. Boat, J.A. Stockman, Edward B. Clark, (unknown), Gerald S. Gilchrist, Richard B. Colletti, Harland S. Winter	5
2	Severe 6-Thioguanine-induced Marrow Aplasia in a Child With Acute Lymphoblastic Leukemia and Inherited Thiopurine Methyltransferase Deficiency 2000 ·The American journal of pediatric hematology/oncology ·Kim L. McBride, Gerald S. Gilchrist, W. Anthony Smithson, Richard M. Weinshilboum, Carol L. Szumlanski	31
3	Langerhans cell histiocytosis 1999 ·Cancer ·Douglas M. Howarth, Gerald S. Gilchrist, Brian P. Mullan, Gregory A. Wiseman, John H. Edmonson, Paula J. Schomberg	480
4	MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial. 1998 ·Journal of Clinical Oncology ·Ray Hutchinson, Christopher Fryer, P Davis, James B. Nachman, Mark Krailo, Richard T. O’Brien, Robert D. Collins, Thomas V. Whalen, David A. Reardon, M Trigg, Gerald S. Gilchrist	59
5	Intraoperative electron irradiation in the management of pediatric malignancies 1997 ·Cancer ·Paula J. Schomberg, Leonard L. Gunderson, Christopher R. Moir, Gerald S. Gilchrist, William A. Smithson	15
6	Dose Reduction of Chemotherapeutic Agents after Weight Loss 1997 ·American Journal of Clinical Oncology ·Aengus O’Marcaigh, Gerald S. Gilchrist	1
7	Childhood Acute Lymphoblastic Leukemia: Are Routine End-of-Therapy Bone Marrow and Cerebrospinal Fluid Examinations Necessary? 1996 ·Mayo Clinic Proceedings ·(unknown), Hernan Sabio, Gerald S. Gilchrist, (unknown)	6
8	Langerhans' cell histiocytosis (histiocytosis X) of bone a clinicopathologic analysis of 263 pediatric and adult cases 1995 ·Cancer ·Scott E. Kilpatrick, Doris E. Wenger, Gerald S. Gilchrist, (unknown), Peter C. Wollan, K. Krishnan Unni	197
9	Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report. 1993 ·Journal of Clinical Oncology ·D G Tubergen, Gerald S. Gilchrist, Richard T. O’Brien, Peter F. Coccia, Harland N. Sather, Mary J. Waskerwitz, G. Denman Hammond	107
10	Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. 1993 ·Journal of Clinical Oncology ·D G Tubergen, Gerald S. Gilchrist, Richard T. O’Brien, Peter F. Coccia, Harland N. Sather, Mary J. Waskerwitz, G. Denman Hammond	167
11	Isoleucine³⁹⁷is changed to threonine in two females with hemophilia B 1991 ·Nucleic Acids Research ·Gobinda Sarkar, Joslyn Cassady, (unknown), Gerald S. Gilchrist, S. S. Sommer	2
12	The intergroup Hodgkin's disease in children. A study of stages I and II 1990 ·Cancer ·E. Gehan, M. P. Sullivan, Lillian M. Fuller, Janet M. Johnston, Peter S. Kennedy, Christopher Fryer, Gerald S. Gilchrist, D.M. Hays, (unknown), R. Heller, R. D. T. Jenkin, Faith Kung, William W. Sheehan, Mariella C. Tefft, Ternberg Jl, Moody D. Wharam	33
13	Cardiopulmonary Function in Long-Term Survivors of Childhood Hodgkin's Lymphoma: A Pilot Study 1988 ·Mayo Clinic Proceedings ·Richard Kadota, E. Omer Burgert, David J. Driscoll, Richard G. Evans, Gerald S. Gilchrist	32
14	Management of Hemophilia A and B During Surgical Correction of Transposition of the Great Arteries 1983 ·Mayo Clinic Proceedings ·(unknown), Gerald S. Gilchrist, F J Kazmier, Robert Feldt, Gordon K. Danielson	16
15	High-Dose Methotrexate with a Safe Rescue Program 1981 ·Oncology ·David A. Decker, J Edmonson, Gerald S. Gilchrist, J. S. Kovach, (unknown), William F. Taylor	1
16	Management of stages I to III Hodgkin disease in children 1980 ·The Journal of Pediatrics ·(unknown), Gerald S. Gilchrist, E. Omer Burgert, Robert L. Telander, Roger E. Cupps	12
17	Response to influenza virus vaccine in children receivingchemotherapy for malignancy 1978 ·The Journal of Pediatrics ·William A. Smithson, R. A. Siem, Roy E. Ritts, Gerald S. Gilchrist, E. Omer Burgert, Duane M. Ilstrup, Thomas F. Smith	34
18	Induction of remission in acute leukemia with prednisone and intravenous methotrexate 1968 ·The Journal of Pediatrics ·Charles Brubaker, Gerald S. Gilchrist, Denman Hammond, C Hyman, Nomie A. Shore, (unknown)	9
19	Thrombosis, nephrosis, and corticosteroid therapy 1968 ·The Journal of Pediatrics ·Ellin Lieberman, Eva Heuser, Gerald S. Gilchrist, George N. Donnell, Benjamin H. Landing	53
20	Familial leukemia and osteogenesis imperfecta 1967 ·The Journal of Pediatrics ·Gerald S. Gilchrist, Nomie A. Shore	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact